Organicell Among Key Industry Experts Discussing the Impact of long-haul COVID on Drug Development in a Virtual Roundtable hosted by Parexel

“As progress is made in addressing the COVID-19 pandemic with vaccines and treatment pathways, reports about the long-term effects of the infection are building.”

Pharmaceutical Executive in collaboration with Parexel organized a roundtable of experts from various stake-holder groups, including Organicell’s Chief Science Officer Dr. Mari Mitrani, to discuss the current research into long-haul COVID.

Read more in the article resulting from the roundtable discussion